Finance

Lists
Why is ETRA up 4.18%?
Dive Deeper
ETRA:NASDAQ
Electra Therapeutics Inc
$8.97
+4.18%
(+0.36) 1D
Oct 20, 2:31:09 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ETRA...
Open
$8.75
High
$9.17
Low
$8.72
Mkt. cap
563.02M
Avg. vol.
592.01K
Volume
74.35K
52-wk high
$15.50
52-wk low
$8.50
No. of employees
46
Open
$8.75
High
$9.17
Low
$8.72
Mkt. cap
563.02M
Avg. vol.
592.01K
Volume
74.35K
52-wk high
$15.50
52-wk low
$8.50
No. of employees
46
News stories
From web sources and news partners
About Electra Therapeutics Inc
CEO-
Employees46
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to ETRA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ETRA in the last 3 months.
Highest
Current $8.97
$36.00 (+301.34%)
Average
$25.77 (+187.29%)
Lowest
$9.32 (+3.90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Akash Tewari
Jefferies
Buy
Initiated
$32.00
+256.7%
10/13/2026
Eric Schmidt FCA
Cantor Fitzgerald
Buy
Initiated
-
-
10/13/2026
Cory Kasimov
Evercore ISI
Buy
Initiated
$36.00
+301.3%
10/13/2026
Tyler Van Buren
TD Cowen
Buy
Initiated
$9.32
+3.9%
10/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.40M
9.40M
20.82M
20.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.29M
3.29M
4.30M
4.30M
Operating expense
12.68M
12.68M
25.12M
25.12M
Total operating expenses
12.68M
12.68M
25.12M
25.12M
Operating income
-12.68M
-12.68M
-25.12M
-25.12M
Other non operating income
-
-
-
-
EBT including unusual items
-12.68M
-12.68M
-24.46M
-24.46M
EBT excluding unusual items
-12.68M
-12.68M
-24.46M
-24.46M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.68M
-12.68M
-24.46M
-24.46M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
168.50K
168.50K
660.00K
660.00K
Interest expense
-163.50K
-163.50K
-
-
Net interest expenses
5.00K
5.00K
660.00K
660.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-25.05M
-25.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps